Side-by-side comparison of AI visibility scores, market position, and capabilities
Employee mental health measurement and wellbeing platform for SMB employers with anonymized workforce assessments; $150K YC W20-backed competing with Lyra and Modern Health in employer mental health benefits.
Hellometer is a Santa Monica-based employee wellbeing and mental health platform founded in 2020 that provides businesses with tools to measure and improve workforce mental health — offering wellbeing assessments, resources, and manager tools that help companies understand the mental health status of their workforce and provide appropriate support. Backed by Y Combinator (W20) with $150,000 from investors including LAUNCH Fund, Intel Ignite, and Bling Capital, Hellometer operates in the growing employer mental health benefits market.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.